Minimal further treatment for DME needed at year 5 in Protocol I study

SAN DIEGO — Visual acuity gains achieved during the first year of treatment with ranibizumab and prompt or deferred laser in patients with diabetic macular edema are maintained through 5 years, with minimal further treatment needed after 3 years, according to a speaker here.John A. Wells III, MD, described the 5-year extended follow-up of the Diabetic Retinopathy Clinical Research Network (DRCR) Protocol I for treatment of DME at the American Society of Retina Specialists annual meeting.

Full Story →